NCT00988767View on ClinicalTrials.gov

Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

November 30, 2003

Study Completion Date

October 31, 2004

Conditions
Chronic Hepatitis B
Interventions
BIOLOGICAL

DNA vaccine

patients received 1ml of DNA vaccine (1mg/ml) at Months 0,2,4,10

Trial Locations (1)

75015

Service d'Hepatologie, Hopital Necker Enfants Malades, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT00988767 - Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter